Dow Jones

38,686.32

1.51%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)
Angiotech Pharmaceuticals - Common Shares (MM) (ANPI) Noticias

ANPI

Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

Angiotech Pharmaceuticals - Common Shares (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ANPI

1 2 3 4 5 6 7 8 9 10 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
13/01/2011	11:00	PR Newswire (US)	ANGIOTECH PHARMACEUTICALS ANNOUNCES DELISTING FROM THE NASDAQ STOCK MARKET AND TRANSFER TO OTCQB™ MARKETPLACE	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
12/01/2011	14:00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support Agreem	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
06/01/2011	16:26	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
05/01/2011	19:00	PR Newswire (US)	ANGIOTECH PHARMACEUTICALS ANNOUNCES NOTICE OF DELISTING FROM THE NASDAQ STOCK MARKET	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
22/12/2010	13:30	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Announces Agreement to Extend Cure Period Under Subordinated Note Indenture	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
02/12/2010	11:18	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Announces Preliminary Injunction Ruling In Connection With Rex Medical L.P. Litigation	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
29/11/2010	11:30	PR Newswire (US)	ANGIOTECH PHARMACEUTICALS ANNOUNCES PRIVATE LABEL PRODUCT SUPPLY AGREEMENT WITH HOLOGIC	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
24/11/2010	13:15	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Announces Commencement of Proceedings by Rex Medical LP	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
16/11/2010	16:08	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
09/11/2010	04:00	PR Newswire (US)	ANGIOTECH PHARMACEUTICALS, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2010	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
29/10/2010	19:00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
29/10/2010	19:00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Announces a Strongly Supported Transaction Agreement with Majority of Senior Subordinated Noteho	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
13/10/2010	18:00	PR Newswire (US)	ANGIOTECH PHARMACEUTICALS ANNOUNCES CONFERENCE CALL AND WEBCAST	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
06/10/2010	07:00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Announces Commencement of Arbitration and Litigation Proceedings by QSR Holdings, Inc. Against t	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
01/10/2010	07:00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Defers Interest Payments Under Senior Subordinated Notes. Angiotech Conducting Discussions With	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
24/09/2010	10:30	PR Newswire (US)	ANGIOTECH ANNOUNCES THAT COOK MEDICAL'S ZILVER(R) PTX(R) DRUG-ELUTING STENT MEETS ITS PRIMARY ENDPOINT IN A 479-PATIENT, MULTI-C	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
23/09/2010	13:30	PR Newswire (US)	ANGIOTECH PHARMACEUTICALS AND PARTNER ATHERSYS ANNOUNCE UPDATED RESULTS FROM PHASE I STUDY OF MULTISTEM(R) IN HEART ATTACK PATIE	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
22/09/2010	13:45	PR Newswire (US)	ANGIOTECH ANNOUNCES STRONG OUTCOMES IN DIABETIC PATIENTS TREATED WITH BOSTON SCIENTIFIC CORPORATION'S PLATINUM CHROMIUM TAXUS(R)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
22/09/2010	13:45	PR Newswire (US)	ANGIOTECH ANNOUNCES LONG-TERM DATA SHOW ADVANTAGES FOR TAXUS(R) LIBERTÉ(R) STENT IN SMALL VESSELS AND LONG LESIONS	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
09/08/2010	15:40	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
09/08/2010	15:31	Dow Jones News	UPDATE:FDA Warns About Long-Term Problems With Blood-Clot Device	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
09/08/2010	14:22	Dow Jones News	FDA Warns About Long-Term Problems With Blood-Clot Device	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
30/07/2010	07:00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
28/07/2010	15:23	PR Newswire (US)	Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack pati	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
08/07/2010	12:00	PR Newswire (US)	Angiotech Pharmaceuticals announces notice of failure to satisfy a continued listing rule with The Nasdaq Stock Market.	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
24/06/2010	12:00	PR Newswire (US)	Angiotech Pharmaceuticals Announces Conference Call and Webcast	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
16/06/2010	05:03	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
11/06/2010	12:00	PR Newswire (US)	Angiotech's licensee, Cook Medical, files PMA submission for FDA approval of Zilver(R) PTX(R) Drug-Eluting Stent platform	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
10/06/2010	17:30	PR Newswire (US)	Angiotech Pharmaceuticals announces acceptance of 2010 medical design excellence award for Quill(TM) SRS	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
10/06/2010	13:00	PR Newswire (US)	Angiotech Pharmaceuticals announces European launch and first implants of Boston Scientific Corporation's platinum chromium TAXU	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)